On May 8, 2024, AbbVie Inc announced that it held its annual general meeting of shareholders on May 3, 2024 and declared voting results. The Company stated that the shareholders' proposal submitted by John Chevedden, on behalf of Kenneth Steiner, regarding a simple majority vote was not presented at the 2024 Annual Shareholder Meeting.
Market Closed -
Other stock markets
|
Pre-market 07:00:06 | |||
171.5 USD | +1.50% |
|
170.5 | -0.59% |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
06-28 | AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.68% | 303B | |
+55.32% | 815B | |
+42.99% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+16.17% | 242B | |
+2.13% | 224B | |
+13.33% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Declaration of Voting Results of the AbbVie Inc